Renal Cancer - Results from #3180

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients. November 22, 2019

The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience. November 22, 2019

A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer. November 22, 2019

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer November 21, 2019

Cytoreductive nephrectomy: does CARMENA (Cancer du Rein Metastatique Nephrectomie et Antiangioge [Combining Acute Accent]niques) change everything? November 21, 2019

Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders. November 21, 2019

Surgical margin follow-up after nephron-sparing surgery: the possible role of CEUS. November 21, 2019

Renal Artery Embolization Before Radical Nephrectomy for Complex Renal Tumour: Which are the True Advantages? November 20, 2019

The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. November 20, 2019

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features. November 20, 2019

Biomarkers in renal-cell carcinoma: building on clinical paradigms. November 20, 2019

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214. November 19, 2019

Adenosine A2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. November 19, 2019

The incidence, predictors, and survival of disappearing small renal masses on active surveillance. November 19, 2019

A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). November 18, 2019

Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma. November 18, 2019

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. November 18, 2019

The Microbiome in Benign Renal Tissue and in Renal Cell Carcinoma. November 15, 2019

Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment. November 15, 2019

Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. November 15, 2019

Page 160 of 457